View of Changes in PD-1- and CTLA-4-bearing Blood Lymphocytes in ICU COVID-19 Patients Treated with Favipiravir/Kaletra or Dexamethasone/Remdesivir: A Pilot Study

Return to Article Details Changes in PD-1- and CTLA-4-bearing Blood Lymphocytes in ICU COVID-19 Patients Treated with Favipiravir/Kaletra or Dexamethasone/Remdesivir: A Pilot Study Download Download PDF